Source: https://finance.yahoo.com/news/moderna-agrees-pay-2-25-212613359.html

    Moderna has agreed to pay Genevant Sciences, a ‌subsidiary of Roivant Sciences, and Arbutus ‌Biopharma up to $2.25 billion to settle a ​long-running legal fight over the technology that made its COVID-19 vaccine possible, the companies said on Tuesday.

    Under the deal, ‌Moderna will ⁠pay $950 million upfront in July 2026, with an additional $1.3 billion ⁠that depends on the outcome of a separate legal appeal.

    In extended trading, ​Moderna's shares ​jumped more than ​10%, Arbutus rose ‌11%, while Roivant was up about 1%.

    The deal resolves all U.S. and international legal actions accusing Moderna of using lipid nanoparticle, or LNP, a delivery ‌technology owned by ​Genevant and Arbutus, without ​permission in ​its COVID‑19 shot, Spikevax.

    LNP technology ‌acts as a tiny ​protective shell ​that helps fragile mRNA molecules reach human cells intact, a key ​component that ‌allows mRNA vaccines to work.

    https://preview.redd.it/svbkm91jgwmg1.png?width=1682&format=png&auto=webp&s=5abdb72fb2b1ce51412141e3f6eb063b6e0f0263

    Moderna +10% after-hours as Moderna agrees to pay up to $2.25B to settle COVID vaccine patent dispute
    byu/callsonreddit inwallstreetbets



    Posted by callsonreddit

    6 Comments

    1. Affectionate-Day2743 on

      up 10% despite agreeing to pay out $2.2 billion? that doesn’t make sense. is $2.2B *less* than what was expected?

    2. No_Mercy_4_Potatoes on

      What what? So they are paying a settlement and the stock jumped? This market is so retarded.

    Leave A Reply
    Share via